Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 212 clinical trials
ProSpace Balloon System Pivotal Study BP-007

The ProSpace System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the ProSpace System to reduce the radiation dose delivered to the anterior rectum. ProSpace is a balloon composed of …

adenocarcinoma
adenocarcinoma of prostate
Chesapeake Urology Research Associates
 (0.5 away) Contact site
  • 183 views
  • 30 Jul, 2020
  • +14 other locations
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery …

lobular carcinoma in situ
tumor cells
cancer
diabetes
carcinoma
Greater Baltimore Medical Center
 (9.3 away) Contact site
  • 335 views
  • 23 Nov, 2020
  • +863 other locations
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

aspirin
total knee replacement
warfarin
rivaroxaban
embolism
Sinai Hospital
 (7.7 away) Contact site
  • 324 views
  • 07 Sep, 2020
  • +34 other locations
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

This randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic). Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor …

tumor cells
liver metastasis
ct scan
measurable disease
cancer
UM Saint Joseph Medical Center
 (9.3 away) Contact site
  • 438 views
  • 02 Dec, 2020
  • +404 other locations
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

This phase III trial studies iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Crizotinib may stop the growth of tumor cells by blocking …

ganglioneuroblastoma
conventional surgery
tumor cells
busulfan
high-risk neuroblastoma
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 66 views
  • 02 Dec, 2020
  • +95 other locations
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of participants in heart failure with iron deficiency and with a reduced ejection fraction.

b-type natriuretic peptide
cardiac resynchronization therapy
nt-probnp
nesiritide
iron
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 5316 views
  • 05 Nov, 2020
  • +326 other locations
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

This is a modular, phase I/ phase 1 b, open-label, multicentre study of ceralasertib administered orally in combination with cytotoxic chemotherapy regimens and/or novel anti-cancer agents, to patients with advanced malignancies. The study design allows an investigation of optimal combination dose of ceralasertib with other anti-cancer treatments, with intensive safety …

Research Site
 (7.6 away) Contact site
  • 64 views
  • 11 Nov, 2020
  • +20 other locations
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

The purpose of this study is to determine the long-term safety of RPC1063 for the treatment of all patients with moderate to severe Ulcerative Colitis (UC) as well as the long-term efficacy of RPC1063 for the treatment of adult patients with moderate to severe UC. Additionally, to determine the long-term …

mercaptopurine
prednisone
endoscopy
methotrexate
aminosalicylates
Woodholme Gastroenterology
 (6.7 away) Contact site
  • 0 views
  • 07 Oct, 2020
  • +293 other locations
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemotherapy administered prior to surgery compared with placebo and chemotherapy administered prior to surgery in terms of major pathological response.

lung carcinoma
cancer chemotherapy
durvalumab
paclitaxel
gemcitabine
Research Site
 (9.3 away) Contact site
  • 251 views
  • 26 Nov, 2020
  • +269 other locations
Study to Evaluate the Efficacy Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

This study will assess the efficacy of vibegron compared with placebo in men with overactive bladder (OAB) symptoms on pharmacological therapy for benign prostatic hyperplasia (BPH) as defined by micturition and urgency episodes.

alpha blocker
benign prostatic hypertrophy
vibegron
cancer
nocturia
Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 959 views
  • 24 Aug, 2020
  • +146 other locations